SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Biocon Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532523

INE376G01013

167.0814588

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BIOCON

59390.06

EPS(TTM)

Face Value()

Div & Yield %

0.49

0.1

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	2242.60	2127.30	1992.90	1738.20	2028.40	1988.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2242.60	2127.30	1992.90	1738.20	2028.40	1988.40
Other Income	849.80	207.50	3134.20	187.20	150.20	366.00
Stock Adjustments	54.60	99.10	-3.20	105.80	-36.70	31.40
Total Income	3147.00	2433.90	5123.90	2031.20	2141.90	2385.80
EXPENDITURE :
Raw Materials	1085.40	1033.80	981.00	914.00	761.60	859.10
Power & Fuel Cost	192.00	215.30	279.20	231.00	186.00	193.30
Employee Cost	501.30	452.30	433.80	367.70	390.20	344.80
Other Manufacturing Expenses	163.80	155.40	127.10	130.50	147.00	118.30
Selling & Administrative Expenses	172.00	135.00	112.20	106.70	128.40	208.40
Miscellaneous Expenses	6.90	-28.10	32.90	33.00	66.00	9.90
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	2121.40	1963.70	1966.20	1782.90	1679.20	1733.80
Operating Profit	1025.60	470.20	3157.70	248.30	462.70	652.00
Interest	236.90	198.80	69.60	0.40	0.40	1.20
Gross Profit	788.70	271.40	3088.10	247.90	462.30	650.80
Depreciation	127.80	121.10	116.90	108.20	103.50	98.00
Profit Before Tax	660.90	150.30	2971.20	139.70	358.80	552.80
Tax	30.60	15.10	132.70	60.70	73.50	104.40
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	21.00	15.90	-9.90	-7.10	4.80	7.50
Reported Net Profit	609.30	119.30	2848.40	86.10	280.50	440.90
Extraordinary Items	564.49	13.41	2861.73	2.92	3.00	136.27
Adjusted Net Profit	44.81	105.89	-13.33	83.18	277.50	304.63
Adjustment below Net Profit	-1.30	30.70	29.40	-59.40	30.40	22.60
P & L Balance brought forward	9920.50	9950.60	7132.80	7106.10	6795.20	6391.80
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	60.00	180.10	60.00	0.00	0.00	60.10
P & L Balance carried down	10468.50	9920.50	9950.60	7132.80	7106.10	6795.20
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	30.00	10.00	0.00	0.00
Dividend Per Share(Rs)	0.50	0.50	1.50	0.50	0.00	0.00
Earnings Per Share-Unit Curr	5.07	0.99	23.72	0.72	2.34	3.67
Earnings Per Share(Adj)-Unit Curr	5.07	0.99	23.72	0.72	2.34	3.67
Book Value-Unit Curr	95.98	90.88	90.91	67.40	65.88	62.80
Book Value(Adj)-Unit Curr	95.98	90.88	90.91	67.40	65.88	62.80

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)